Trial Profile
Study of budesonide/formoterol fumarate Easyhaler for patients with poorly controlled obstructive airway disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Aug 2018
Price :
$35
*
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma; Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 06 Aug 2018 New trial record
- 31 Jul 2018 Results published in the Advances in Therapy